Vericel (VCEL) EBIT (2010 - 2026)
Vericel (VCEL) reported EBIT of -$8.1 million for Q1 2026, up 36.96% on a YoY basis from -$5.9 million in Q1 2025, and down 135.98% sequentially from $22.4 million in Q4 2025.
Vericel (VCEL) EBIT (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of EBIT data on file, last reported at -$8.1 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT rose 36.96% year-over-year to -$8.1 million; the trailing twelve-month figure through Mar 2026 stood at $15.8 million (up 661.48% YoY), and the FY2025 full-year result was $11.0 million, up 144.39% from the prior year.
- EBIT fell to -$8.1 million in Q1 2026, from $22.4 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $22.4 million in Q4 2025 to a low of -$12.8 million in Q1 2025.
- A 5-year average of -$942529.4 and a median of -$5.5 million in 2024 frame the typical range for EBIT.
- Across the five-year window, EBIT sank 143.55% in 2022 and jumped 239.96% in 2025, its largest moves.
- Tracing VCEL's EBIT over 5 years: stood at $6.1 million in 2022, then surged by 109.22% to $12.7 million in 2023, then soared by 45.15% to $18.5 million in 2024, then climbed by 21.3% to $22.4 million in 2025, then plunged by 135.98% to -$8.1 million in 2026.
- Business Quant data shows VCEL's EBIT at -$8.1 million in Q1 2026, $22.4 million in Q4 2025, and $3.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | -8.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.06 Mn |
| Dec 31, 2025 | 22.42 Mn |
| Sep 30, 2025 | 3.45 Mn |
| Jun 30, 2025 | -2.03 Mn |
| Mar 31, 2025 | -12.79 Mn |
| Dec 31, 2024 | 18.48 Mn |
| Sep 30, 2024 | -2.47 Mn |
| Jun 30, 2024 | -6.03 Mn |
| Mar 31, 2024 | -5.46 Mn |
| Dec 31, 2023 | 12.73 Mn |
| Sep 30, 2023 | -5.06 Mn |
| Jun 30, 2023 | -5.96 Mn |
| Mar 31, 2023 | -8.18 Mn |
| Dec 31, 2022 | 6.09 Mn |
| Sep 30, 2022 | -6.79 Mn |
| Jun 30, 2022 | -9.08 Mn |
| Mar 31, 2022 | -7.27 Mn |
| Dec 31, 2021 | 4.14 Mn |
| Sep 30, 2021 | -4.96 Mn |
| Jun 30, 2021 | -3.73 Mn |